Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

1,2-dimyristoyl-sn-glycero-3-phosphorylcholine

1,2-dimyristoyl-sn-glycero-3-phosphorylcholine is listed in the pharmaceutical impurity collection under CAS 51779-95-4. Its represented structure has formula C52H100NO8P and a calculated molecular weight of 898.35 g/mol.

2D chemical structure

O O O P O O - O N + O O ( R ) ( Z ) ( Z )

Chemical identity

Catalog name
1,2-dimyristoyl-sn-glycero-3-phosphorylcholine
Common name
1,2-dimyristoyl-sn-glycero-3-phosphorylcholine
Chemical name
[(2R)-2,3-bis[[(Z)-docos-13-enoyl]oxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
CAS
51779-95-4
SMILES
CCCCCCCC/C=C\CCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCC/C=C\CCCCCCCC
InChI
InChI=1S/C52H100NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-38-40-42-44-51(54)58-48-50(49-60-62(56,57)59-47-46-53(3,4)5)61-52(55)45-43-41-39-37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h20-23,50H,6-19,24-49H2,1-5H3/b22-20-,23-21-/t50-/m1/s1
InChIKey
SDEURMLKLAEUAY-JFSPZUDSSA-N

Record ID: Aeed5f6491bce

Computed properties

C52H100NO8P Molecular formula
898.345 g/molMolecular weight
897.7187 DaMonoisotopic exact mass
111.19 ŲTopological polar surface area
14.845 Calculated LogP (Wildman–Crippen)
259.0889 cm³/molMolar refractivity (Wildman–Crippen)
8 countHydrogen-bond acceptors
0 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. 1 potential atom stereocenters have unspecified configuration.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 15 30 45 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O P 0 25 50 75 100 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight898.34598.13
Calculated LogP (Wildman–Crippen)14.84599.89
Topological polar surface area111.1978.04
Hydrogen-bond acceptors887.87
Hydrogen-bond donors011.28
Rotatable bonds (strict)4899.91

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC52H100NO8Pdimensionless
Molecular weight898.345g/mol
Monoisotopic exact mass897.7187Da
Topological polar surface area111.19Ų
Calculated LogP (Wildman–Crippen)14.845dimensionless
Molar refractivity (Wildman–Crippen)259.0889cm³/mol
Hydrogen-bond acceptors8count
Hydrogen-bond donors0count
Rotatable bonds (strict)48count
Heavy atoms62count
Heteroatoms10count
Rings0count
Aromatic rings0count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles0count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.8846fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters2count
Unspecified atom stereocenters1count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area383.063Ų
Valence electrons366count
Radical electrons0count
Bertz complexity1,106.824index
Balaban J4.2321index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for 1,2-dimyristoyl-sn-glycero-3-phosphorylcholine

Qualification and safety assessment of 1,2-dimyristoyl-sn-glycero-3-phosphorylcholine

Explore toxicological qualification of 1,2-dimyristoyl-sn-glycero-3-phosphorylcholine and ICH M7 mutagenic impurity assessment of 1,2-dimyristoyl-sn-glycero-3-phosphorylcholine for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for 1,2-dimyristoyl-sn-glycero-3-phosphorylcholine and acceptable intake and limit justification for 1,2-dimyristoyl-sn-glycero-3-phosphorylcholine. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for 1,2-dimyristoyl-sn-glycero-3-phosphorylcholine

Explore Altox services and software through the Altox Pharma-Hub.